Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis

Conclusions: Epidemiological evidence supports the potential of vitamin B6 as a cancer risk reduction agent and the role of PLP as a cancer screening biomarker, especially for gastrointestinal tumors. However, inconsistent findings from total intake and intervention studies suggest that vitamin B6 might also be an indicator of other dietary protective micronutrients.

Source: JNCI - October 29, 2016 Category: Cancer & Oncology Authors: Mocellin, S., Briarava, M., Pilati, P. Tags: Review Source Type: research